|
1
|
The global burden of disease: 2004 update.
WHO Library Cataloguing-in-Publication Data. 2008, http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.
|
|
2
|
Cancer statistics: Worldwide. World Cancer
Research Fund International Web site. http://www.wcrf.org/int/cancer-facts-figures/worldwide-data.
|
|
3
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Phan LM, Yeung SC and Lee MH: Cancer
metabolic reprogramming: importance, main features, and potentials
for precise targeted anti-cancer therapies. Cancer Biol Med.
11:1–19. 2014.PubMed/NCBI
|
|
5
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirayama A, Kami K, Sugimoto M, et al:
Quantitative metabolome profiling of colon and stomach cancer
microenvironment by capillary electrophoresis time-of-flight mass
spectrometry. Cancer Res. 69:4918–4925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Soga T, Baran R, Suematsu M, et al:
Differential metabolomics reveals ophthalmic acid as an oxidative
stress biomarker indicating hepatic glutathione consumption. J Biol
Chem. 281:16768–16776. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saito K: Phytochemical genomics - a new
trend. Curr Opin Plant Biol. 16:373–380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mashego MR, Rumbold K, De Mey M, Vandamme
E, Soetaert W and Heijnen JJ: Microbial metabolomics: past, present
and future methodologies. Biotechnol Lett. 29:1–16. 2007.
View Article : Google Scholar
|
|
10
|
Spratlin JL, Serkova NJ and Eckhardt SG:
Clinical applications of metabolomics in oncology: a review. Clin
Cancer Res. 15:431–440. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oliver S: Guilt-by-association goes
global. Nature. 403:601–603. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fiehn O: Metabolomics - the link between
genotypes and phenotypes. Plant Mol Biol. 48:155–171. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu WK, Wang G, Coffelt SB, et al: Emerging
roles of the host defense peptide LL-37 in human cancer and its
potential therapeutic applications. Int J Cancer. 127:1741–1747.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zaiou M and Gallo RL: Cathelicidins,
essential gene-encoded mammalian antibiotics. J Mol Med (Berl).
80:549–561. 2002. View Article : Google Scholar
|
|
15
|
Zanetti M: The role of cathelicidins in
the innate host defenses of mammals. Curr Issues Mol Biol.
7:179–196. 2005.PubMed/NCBI
|
|
16
|
Bals R, Wang X, Zasloff M and Wilson JM:
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of
the human lung where it has broad antimicrobial activity at the
airway surface. Proc Natl Acad Sci USA. 95:9541–9546. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ren SX, Cheng AS, To KF, et al: Host
immune defense peptide LL-37 activates caspase-independent
apoptosis and suppresses colon cancer. Cancer Res. 72:6512–6523.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okumura K, Itoh A, Isogai E, et al:
C-terminal domain of human CAP18 antimicrobial peptide induces
apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer
Lett. 212:185–194. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuroda K, Fukuda T, Yoneyama H, et al:
Anti-proliferative effect of an analogue of the LL-37 peptide in
the colon cancer derived cell line HCT116 p53+/+ and
p53. Oncol Rep. 28:829–834. 2012.PubMed/NCBI
|
|
20
|
Isogai E, Isogai H, Matuo K, et al:
Sensitivity of genera Porphyromonas and Prevotella to the
bactericidal action of C-terminal domain of human CAP18 and its
analogues. Oral Microbiol Immunol. 18:329–332. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Soga T and Heiger DN: Amino acid analysis
by capillary electrophoresis electrospray ionization mass
spectrometry. Anal Chem. 72:1236–1241. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Soga T, Ueno Y, Naraoka H, Ohashi Y,
Tomita M and Nishioka T: Simultaneous determination of anionic
intermediates for Bacillus subtilis metabolic pathways by capillary
electrophoresis electrospray ionization mass spectrometry. Anal
Chem. 74:2233–2239. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Soga T, Ohashi Y, Ueno Y, Naraoka H,
Tomita M and Nishioka T: Quantitative metabolome analysis using
capillary electrophoresis mass spectrometry. J Proteome Res.
2:488–494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sugimoto M, Wong DT, Hirayama A, Soga T
and Tomita M: Capillary electrophoresis mass spectrometry-based
saliva metabolomics identified oral, breast and pancreatic
cancer-specific profiles. Metabolomics. 6:78–95. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Junker BH, Klukas C and Schreiber F:
VANTED: a system for advanced data analysis and visualization in
the context of biological networks. BMC Bioinformatics. 7:1092006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gaspar D, Veiga AS and Castanho MA: From
antimicrobial to anticancer peptides. A review. Front Microbiol.
4:2942013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu D, Gao Y, Qi Y, Chen L, Ma Y and Li Y:
Peptide-based cancer therapy: opportunity and challenge. Cancer
Lett. 351:13–22. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bensaad K, Tsuruta A, Selak MA, et al:
TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell.
126:107–120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu Y, Benedict MA, Ding L and Nunez G:
Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated
caspase-9 activation and apoptosis. EMBO J. 18:3586–3595. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li P, Nijhawan D, Budihardjo I, et al:
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9
complex initiates an apoptotic protease cascade. Cell. 91:479–489.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kass GE, Eriksson JE, Weis M, Orrenius S
and Chow SC: Chromatin condensation during apoptosis requires ATP.
Biochem J. 318:749–752. 1996.PubMed/NCBI
|
|
32
|
Barros LF, Kanaseki T, Sabirov R, et al:
Apoptotic and necrotic blebs in epithelial cells display similar
neck diameters but different kinase dependency. Cell Death Differ.
10:687–697. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leist M, Single B, Castoldi AF, Kuhnle S
and Nicotera P: Intracellular adenosine triphosphate (ATP)
concentration: a switch in the decision between apoptosis and
necrosis. J Exp Med. 185:1481–1486. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zamaraeva MV, Sabirov RZ, Maeno E,
Ando-Akatsuka Y, Bessonova SV and Okada Y: Cells die with increased
cytosolic ATP during apoptosis: a bioluminescence study with
intracel-lular luciferase. Cell Death Differ. 12:1390–1397. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gentilucci L, Tolomelli A and Squassabia
F: Peptides and pepti-domimetics in medicine, surgery and
biotechnology. Curr Med Chem. 13:2449–2466. 2006. View Article : Google Scholar
|
|
37
|
Hancock RE and Diamond G: The role of
cationic antimicrobial peptides in innate host defences. Trends
Microbiol. 8:402–410. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ren SX, Shen J, Cheng AS, et al: FK-16
derived from the anti-cancer peptide LL-37 induces
caspase-independent apoptosis and autophagic cell death in colon
cancer cells. PLoS One. 8:e636412013. View Article : Google Scholar
|
